Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v4-FR
Language French French
Date Updated 2021-08-16 2020-04-07
Drug Identification Number 00013579 00013579
Brand name GRAVOL IM GRAVOL IM
Common or Proper name DIMENHYDRINATE INJECTION DIMENHYDRINATE INJECTION
Company Name CHURCH & DWIGHT CANADA CORP CHURCH & DWIGHT CANADA CORP
Ingredients DIMENHYDRINATE DIMENHYDRINATE
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10 X 1 mL 10 X 1 mL
ATC code R06AA R06AA
ATC description ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2020-04-06
Actual start date 2020-10-09 2020-04-06
Estimated end date 2020-12-22 2020-12-18
Actual end date 2020-12-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Due to the current situation (Covid-19) we are not able to pull forward any production. Therefore we can no longer meet demand of any of our clients. Due to the current situation (Covid-19) we are not able to pull forward any production. Therefore we anticipate that we can no longer meet demand of all our clients.
Health Canada comments